Clinical trials: Veisalgia
Alcohol Consumption, Alcohol
Rapid BAC Reduction with Nutraceutical Blend Study
Study Title: Nutritional Supplement to Rapidly Decrease Blood Alcohol Concentration (BAC): Safety and Efficacy Study Design: Double-blind, randomized, placebo-controlled clinical trial Objective: Evaluate safety and efficacy of a…
- Conditions
- Alcohol Consumption, Alcohol, Hangover Symptoms, NAC, Veisalgia
- Trial name
- NCT06722898
- Testing
- Supplement
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- Medical Life Care Planners, LLC
Veisalgia
Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001
This will be a double-blind, placebo-controlled study with a 4-way crossover design with subjects administered study drug (JMI-001), placebo, fexofenadine alone and naproxen alone on different study days, in conjunction with a…
- Trial name
- NCT03183297
- Testing
- JMI-001, Naproxen, Fexofenadine
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Sen-Jam Pharmaceutical
Veisalgia
Safety and Efficacy of a Combination Product for the Prevention of Veisalgia
The purpose of this study is to determine the safety and efficacy of a combination product for the prevention of veisalgia. Common symptoms of veisalgia following the moderate consumption of alcohol includes headache, fatigue…
- Trial name
- NCT02737397
- Testing
- JMI-001 (SJP-304 and SJP-223), SJP-304, SJP-223
- Volunteers
- 13 people, healthy volunteers welcome
- Sponsor
- Sen-Jam Pharmaceutical